{
  "resourceType": "Bundle",
  "id": "eumfh-39-02-1",
  "meta": {
      "versionId": "1",
      "lastUpdated": "2021-05-18T15:37:04.033Z"
  },
  "identifier": {
      "system": "http://trilliumbridge.eu/fhir/demos/eumfh/inject",
      "value": "EUR01P0004"
  },
  "type": "document",
  "timestamp": "2021-05-18T08:38:00+02:00",
  "entry": [
      {
          "fullUrl": "urn:uuid:2fa5b223-ebce-4f39-9c66-5dc014f73572",
          "resource": {
              "resourceType": "Composition",
              "id": "eumfh-39-02-1",
              "status": "final",
              "type": {
                  "coding": [
                      {
                          "code": "60591-5",
                          "system": "http://loinc.org",
                          "display": "Patient summary Document"
                      }
                  ]
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "date": "2018-07-10T15:22:00+02:00",
              "author": [
                  {
                      "reference": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
                      "display": "Dr. Anna Karlsson"
                  }
              ],
              "title": "Patient Summary - Inject 39-02-1",
              "confidentiality": "N",
              "section": [
                  {
                      "title": "Allergies and Intolerances",
                      "code": {
                          "coding": [
                              {
                                  "code": "48765-2",
                                  "system": "http://loinc.org",
                                  "display": "Allergies and adverse reactions Document"
                              }
                          ]
                      },
                      "text": {
                          "status": "generated",
                          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Penicillins with extended spectrum</li></ul></div>"
                      },
                      "entry": [
                          {
                              "reference": "urn:uuid:1dff4474-fa08-4f45-8260-dbb23094bf07",
                              "display": "Penicillins with extended spectrum"
                          }
                      ]
                  },
                  {
                      "title": "Active Problems",
                      "code": {
                          "coding": [
                              {
                                  "code": "11450-4",
                                  "system": "http://loinc.org",
                                  "display": "Problem list Reported"
                              }
                          ]
                      },
                      "text": {
                          "status": "generated",
                          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Mild cognitive impairment</li><li>Chronic kidney disease, stage 3</li><li>Prostate Cancer</li><li>Type 2 diabetes mellitus</li><li>Glaucoma</li><li>Essential (primary) hypertension</li><li>Hypothyroidism, unspecified</li></ul></div>"
                      },
                      "entry": [
                          {
                              "reference": "urn:uuid:bcc79261-142c-48ec-b032-f3f9af49ec58",
                              "display": "Mild cognitive impairment"
                          },
                          {
                              "reference": "urn:uuid:a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
                              "display": "Chronic kidney disease, stage 3"
                          },
                          {
                              "reference": "urn:uuid:98ac46eb-0b95-4497-97e0-edc965c2b34e",
                              "display": "Prostate Cancer"
                          },
                          {
                              "reference": "urn:uuid:358b5eb9-f2da-455b-8d75-b1549e7455e4",
                              "display": "Type 2 diabetes mellitus"
                          },
                          {
                              "reference": "urn:uuid:bf8af691-44ad-49db-a444-792b5d8d5df6",
                              "display": "Glaucoma"
                          },
                          {
                              "reference": "urn:uuid:f06b7cf8-c15c-4288-a0f9-45a1026e5130",
                              "display": "Essential (primary) hypertension"
                          },
                          {
                              "reference": "urn:uuid:3575048a-6175-4d8b-931b-c5fb6c0b458d",
                              "display": "Hypothyroidism, unspecified"
                          }
                      ]
                  },
                  {
                      "title": "Medication",
                      "code": {
                          "coding": [
                              {
                                  "code": "10160-0",
                                  "system": "http://loinc.org",
                                  "display": "Hx of Medication use"
                              }
                          ]
                      },
                      "text": {
                          "status": "generated",
                          "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><thead><tr><th>Medication</th><th>Dosage</th></tr></thead><tbody><tr><td>Gliclazide</td><td>80 mg/day</td></tr><tr><td>Acetylsalicylic acid</td><td>75 mg/day</td></tr><tr><td>Metformin</td><td>500 mg twice a day</td></tr><tr><td>Finasteride</td><td>5 mg/day</td></tr><tr><td>tamsulosin</td><td>0.4 mg/day</td></tr><tr><td>latanoprost</td><td>55 ug/day</td></tr><tr><td>Timolol</td><td>0.25 %, 1 times per 2 day</td></tr><tr><td>Atorvastatin</td><td>40 mg/day</td></tr><tr><td>Atenolol</td><td>50 mg/day</td></tr><tr><td>Bendroflumethiazide</td><td>2.5 mg/day</td></tr><tr><td>Lisinopril</td><td>10 mg/day</td></tr><tr><td>levothyroxine sodium</td><td>100 ug/day</td></tr></tbody></table></div>"
                      },
                      "entry": [
                          {
                              "reference": "urn:uuid:29074ca4-efcb-4ff4-8446-feed2399a899",
                              "display": "Gliclazide 80 mg/day"
                          },
                          {
                              "reference": "urn:uuid:f6cb1218-f81c-4338-80d8-3c10910f78fd",
                              "display": "Acetylsalicylic acid 75 mg/day"
                          },
                          {
                              "reference": "urn:uuid:f26084c9-b1c8-46d9-acb2-1d400ade87ba",
                              "display": "Metformin 500 mg twice a day"
                          },
                          {
                              "reference": "urn:uuid:9558d523-8b4c-42b6-8d5b-1ede05c52e03",
                              "display": "Finasteride 5 mg/day"
                          },
                          {
                              "reference": "urn:uuid:7bddaf12-86ef-493a-bf09-ae94a27526dc",
                              "display": "tamsulosin 0.4 mg/day"
                          },
                          {
                              "reference": "urn:uuid:7e22ab9c-5b4a-4202-9d2a-7bc07a0e8f5f",
                              "display": "latanoprost 55 ug/day"
                          },
                          {
                              "reference": "urn:uuid:9556c616-fffe-41da-8305-ff58553912a6",
                              "display": "Timolol 0.25 %, 1 times per 2 day"
                          },
                          {
                              "reference": "urn:uuid:ba30004c-33b9-4880-8995-354014be0c62",
                              "display": "Atorvastatin 40 mg/day"
                          },
                          {
                              "reference": "urn:uuid:cc0b3769-76c5-4f28-9348-dab32eb755d2",
                              "display": "Atenolol 50 mg/day"
                          },
                          {
                              "reference": "urn:uuid:29074ca4-efcb-4ff4-8446-feed2399a8990",
                              "display": "Bendroflumethiazide 2.5 mg/day"
                          },
                          {
                              "reference": "urn:uuid:29074ca4-efcb-4ff4-8446-feed2399a8991",
                              "display": "Lisinopril 10 mg/day"
                          },
                          {
                              "reference": "urn:uuid:29074ca4-efcb-4ff4-8446-feed2399a8992",
                              "display": "levothyroxine sodium 100 ug/day"
                          }
                      ]
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
          "resource": {
              "resourceType": "Patient",
              "id": "eumfh-39-02-1",
              "extension": [
                  {
                      "extension": [
                          {
                              "url": "code",
                              "valueCodeableConcept": {
                                  "coding": [
                                      {
                                          "code": "GB",
                                          "system": "urn:iso:std:iso:3166",
                                          "display": "United Kingdom of Great Britain and Northern Ireland"
                                      }
                                  ]
                              }
                          }
                      ],
                      "url": "http://hl7.org/fhir/StructureDefinition/patient-citizenship"
                  }
              ],
              "identifier": [
                  {
                      "system": "http://trilliumbridge.eu/fhir/demos/eumfh/inject",
                      "value": "39-02-1"
                  },
                  {
                      "system": "http://trilliumbridge.eu/fhir/demos/eumfh/patient_id",
                      "value": "EUR01P0004"
                  }
              ],
              "active": true,
              "name": [
                  {
                      "family": "Mark",
                      "given": [
                          "John"
                      ]
                  }
              ],
              "gender": "male",
              "birthDate": "1934-06-22"
          }
      },
      {
          "fullUrl": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
          "resource": {
              "resourceType": "Practitioner",
              "id": "eumfh-39-02-1",
              "name": [
                  {
                      "family": "Karlsson",
                      "given": [
                          "Anne"
                      ],
                      "prefix": [
                          "Dr."
                      ]
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:1dff4474-fa08-4f45-8260-dbb23094bf07",
          "resource": {
              "resourceType": "AllergyIntolerance",
              "id": "eumfh-39-02-1-1",
              "clinicalStatus": {
                  "coding": [
                      {
                          "code": "active",
                          "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical"
                      }
                  ]
              },
              "verificationStatus": {
                  "coding": [
                      {
                          "code": "confirmed",
                          "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification"
                      }
                  ]
              },
              "code": {
                  "coding": [
                      {
                          "code": "J01CA",
                          "system": "http://www.whocc.no/atc",
                          "display": "Penicillins with extended spectrum"
                      }
                  ]
              },
              "patient": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              }
          }
      },
      {
          "fullUrl": "urn:uuid:bcc79261-142c-48ec-b032-f3f9af49ec58",
          "resource": {
              "resourceType": "Condition",
              "id": "eumfh-39-02-1-1",
              "clinicalStatus": {
                  "coding": [
                      {
                          "code": "active",
                          "system": "http://terminology.hl7.org/CodeSystem/condition-clinical"
                      }
                  ]
              },
              "code": {
                  "coding": [
                      {
                          "code": "386805003",
                          "system": "http://snomed.info/sct",
                          "display": "Mild cognitive impairment"
                      }
                  ],
                  "text": "Mild cognitive impairment"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "onsetDateTime": "2015-08-01",
              "asserter": {
                  "reference": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
                  "display": "Dr. Anna Karlsson"
              }
          }
      },
      {
          "fullUrl": "urn:uuid:a4a9d90a-d1b0-4d60-82f0-c52343dc6256",
          "resource": {
              "resourceType": "Condition",
              "id": "eumfh-39-02-1-2",
              "clinicalStatus": {
                  "coding": [
                      {
                          "code": "active",
                          "system": "http://terminology.hl7.org/CodeSystem/condition-clinical"
                      }
                  ]
              },
              "code": {
                  "coding": [
                      {
                          "code": "433144002",
                          "system": "http://snomed.info/sct",
                          "display": "Chronic kidney disease stage 3"
                      }
                  ],
                  "text": "Chronic kidney disease, stage 3"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "onsetDateTime": "2015-01-01",
              "asserter": {
                  "reference": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
                  "display": "Dr. Anna Karlsson"
              }
          }
      },
      {
          "fullUrl": "urn:uuid:98ac46eb-0b95-4497-97e0-edc965c2b34e",
          "resource": {
              "resourceType": "Condition",
              "id": "eumfh-39-02-1-3",
              "clinicalStatus": {
                  "coding": [
                      {
                          "code": "active",
                          "system": "http://terminology.hl7.org/CodeSystem/condition-clinical"
                      }
                  ]
              },
              "code": {
                  "coding": [
                      {
                          "code": "254900004",
                          "system": "http://snomed.info/sct",
                          "display": "Prostate Cancer"
                      }
                  ],
                  "text": "Prostate Cancer"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "onsetDateTime": "2010-10-02",
              "asserter": {
                  "reference": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
                  "display": "Dr. Anna Karlsson"
              }
          }
      },
      {
          "fullUrl": "urn:uuid:358b5eb9-f2da-455b-8d75-b1549e7455e4",
          "resource": {
              "resourceType": "Condition",
              "id": "eumfh-39-02-1-4",
              "clinicalStatus": {
                  "coding": [
                      {
                          "code": "active",
                          "system": "http://terminology.hl7.org/CodeSystem/condition-clinical"
                      }
                  ]
              },
              "code": {
                  "coding": [
                      {
                          "code": "44054006",
                          "system": "http://snomed.info/sct",
                          "display": "Type 2 diabetes mellitus"
                      }
                  ],
                  "text": "Type 2 diabetes mellitus"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "onsetDateTime": "2010-04-02",
              "asserter": {
                  "reference": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
                  "display": "Dr. Anna Karlsson"
              }
          }
      },
      {
          "fullUrl": "urn:uuid:bf8af691-44ad-49db-a444-792b5d8d5df6",
          "resource": {
              "resourceType": "Condition",
              "id": "eumfh-39-02-1-5",
              "clinicalStatus": {
                  "coding": [
                      {
                          "code": "active",
                          "system": "http://terminology.hl7.org/CodeSystem/condition-clinical"
                      }
                  ]
              },
              "code": {
                  "coding": [
                      {
                          "code": "23986001",
                          "system": "http://snomed.info/sct",
                          "display": "Glaucoma"
                      }
                  ],
                  "text": "Glaucoma"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "onsetDateTime": "1998-05-04",
              "asserter": {
                  "reference": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
                  "display": "Dr. Anna Karlsson"
              }
          }
      },
      {
          "fullUrl": "urn:uuid:f06b7cf8-c15c-4288-a0f9-45a1026e5130",
          "resource": {
              "resourceType": "Condition",
              "id": "eumfh-39-02-1-6",
              "clinicalStatus": {
                  "coding": [
                      {
                          "code": "active",
                          "system": "http://terminology.hl7.org/CodeSystem/condition-clinical"
                      }
                  ]
              },
              "code": {
                  "coding": [
                      {
                          "code": "38341003",
                          "system": "http://snomed.info/sct",
                          "display": "HT - Hypertension"
                      }
                  ],
                  "text": "Essential (primary) hypertension"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "onsetDateTime": "1993-03-02",
              "asserter": {
                  "reference": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
                  "display": "Dr. Anna Karlsson"
              }
          }
      },
      {
          "fullUrl": "urn:uuid:3575048a-6175-4d8b-931b-c5fb6c0b458d",
          "resource": {
              "resourceType": "Condition",
              "id": "eumfh-39-02-1-7",
              "clinicalStatus": {
                  "coding": [
                      {
                          "code": "active",
                          "system": "http://terminology.hl7.org/CodeSystem/condition-clinical"
                      }
                  ]
              },
              "code": {
                  "coding": [
                      {
                          "code": "40930008",
                          "system": "http://snomed.info/sct",
                          "display": "Hypothyroidism"
                      }
                  ],
                  "text": "Hypothyroidism, unspecified"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "onsetDateTime": "1987-03-10",
              "asserter": {
                  "reference": "urn:uuid:1ece89c5-fda3-4db9-ace6-decbe6c603d8",
                  "display": "Dr. Anna Karlsson"
              }
          }
      },
      {
          "fullUrl": "urn:uuid:29074ca4-efcb-4ff4-8446-feed2399a899",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-1",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:b50ae644-e0b7-4007-809f-26f493cbe36b",
                  "display": "Gliclazide"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "2015-05-01"
              },
              "dosage": [
                  {
                      "text": "80 mg/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:f6cb1218-f81c-4338-80d8-3c10910f78fd",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-2",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:de131e15-ed13-4b31-b38c-3204a84d99c4",
                  "display": "Acetylsalicylic acid"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "2012-11-10"
              },
              "dosage": [
                  {
                      "text": "75 mg/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:f26084c9-b1c8-46d9-acb2-1d400ade87ba",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-3",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:9ac3356c-4ea4-4814-84c3-235484f2ef19",
                  "display": "Metformin"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "2010-10-01"
              },
              "dosage": [
                  {
                      "text": "500 mg twice a day",
                      "timing": {
                          "repeat": {
                              "frequency": 2,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:9558d523-8b4c-42b6-8d5b-1ede05c52e03",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-4",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:a000db50-0f78-4103-afd7-6a51d6f122ac",
                  "display": "Finasteride"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "2010-08-04"
              },
              "dosage": [
                  {
                      "text": "5 mg/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:7bddaf12-86ef-493a-bf09-ae94a27526dc",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-5",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:e09a45d9-01db-48a6-a33d-22b49237a660",
                  "display": "tamsulosin"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "2008-02-03"
              },
              "dosage": [
                  {
                      "text": "0.4 mg/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:7e22ab9c-5b4a-4202-9d2a-7bc07a0e8f5f",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-6",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:aeaa0d87-b9e7-481b-9482-a8dd185f6e1d",
                  "display": "latanoprost"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "2004-02-16"
              },
              "dosage": [
                  {
                      "text": "55 ug/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:9556c616-fffe-41da-8305-ff58553912a6",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-7",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:1efd8e7a-fc4c-472a-82c3-e9f897999943",
                  "display": "Timolol"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "1998-08-15"
              },
              "dosage": [
                  {
                      "text": "0.25 %, 1 times per 2 day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 2,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:ba30004c-33b9-4880-8995-354014be0c62",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-8",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:874336dc-7107-45c5-b278-be80f3038608",
                  "display": "Atorvastatin"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "1998-04-02"
              },
              "dosage": [
                  {
                      "text": "40 mg/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:cc0b3769-76c5-4f28-9348-dab32eb755d2",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-9",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:ed6e9cc9-3e61-4d24-830d-fe115307030f",
                  "display": "Atenolol"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "1994-08-03"
              },
              "dosage": [
                  {
                      "text": "50 mg/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:29074ca4-efcb-4ff4-8446-feed2399a8990",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-10",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:4f81d386-80d5-4a22-8b32-892f8b736094",
                  "display": "Bendroflumethiazide"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "1993-09-01"
              },
              "dosage": [
                  {
                      "text": "2.5 mg/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:29074ca4-efcb-4ff4-8446-feed2399a8991",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-11",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:f28d6b82-31bf-4764-9259-12e78aa0374d",
                  "display": "Lisinopril"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "1993-05-02"
              },
              "dosage": [
                  {
                      "text": "10 mg/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:29074ca4-efcb-4ff4-8446-feed2399a8992",
          "resource": {
              "resourceType": "MedicationStatement",
              "id": "eumfh-39-02-1-12",
              "status": "active",
              "medicationReference": {
                  "reference": "urn:uuid:893a36f7-cb07-442f-9ec7-b80d433a493c",
                  "display": "levothyroxine sodium"
              },
              "subject": {
                  "reference": "urn:uuid:c154158f-6a43-4ab7-8443-e7f4bf915dd5",
                  "display": "John Mark (inject 39-02-1)"
              },
              "effectivePeriod": {
                  "start": "1987-04-01"
              },
              "dosage": [
                  {
                      "text": "100 ug/day",
                      "timing": {
                          "repeat": {
                              "frequency": 1,
                              "period": 1,
                              "periodUnit": "d"
                          }
                      }
                  }
              ]
          }
      },
      {
          "fullUrl": "urn:uuid:b50ae644-e0b7-4007-809f-26f493cbe36b",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-1",
              "code": {
                  "coding": [
                      {
                          "code": "A10BB09",
                          "system": "http://www.whocc.no/atc",
                          "display": "Gliclazide"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:de131e15-ed13-4b31-b38c-3204a84d99c4",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-2",
              "code": {
                  "coding": [
                      {
                          "code": "B01AC06",
                          "system": "http://www.whocc.no/atc",
                          "display": "Acetylsalicylic acid"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:9ac3356c-4ea4-4814-84c3-235484f2ef19",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-3",
              "code": {
                  "coding": [
                      {
                          "code": "A10BA02",
                          "system": "http://www.whocc.no/atc",
                          "display": "Metformin"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:a000db50-0f78-4103-afd7-6a51d6f122ac",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-4",
              "code": {
                  "coding": [
                      {
                          "code": "D11AX10",
                          "system": "http://www.whocc.no/atc",
                          "display": "Finasteride"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:e09a45d9-01db-48a6-a33d-22b49237a660",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-5",
              "code": {
                  "coding": [
                      {
                          "code": "G04CA02",
                          "system": "http://www.whocc.no/atc",
                          "display": "tamsulosin"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:aeaa0d87-b9e7-481b-9482-a8dd185f6e1d",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-6",
              "code": {
                  "coding": [
                      {
                          "code": "S01EE01",
                          "system": "http://www.whocc.no/atc",
                          "display": "latanoprost"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:1efd8e7a-fc4c-472a-82c3-e9f897999943",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-7",
              "code": {
                  "coding": [
                      {
                          "code": "S01ED01",
                          "system": "http://www.whocc.no/atc",
                          "display": "Timolol"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:874336dc-7107-45c5-b278-be80f3038608",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-8",
              "code": {
                  "coding": [
                      {
                          "code": "C10AA05",
                          "system": "http://www.whocc.no/atc",
                          "display": "Atorvastatin"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:ed6e9cc9-3e61-4d24-830d-fe115307030f",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-9",
              "code": {
                  "coding": [
                      {
                          "code": "C07AB03",
                          "system": "http://www.whocc.no/atc",
                          "display": "Atenolol"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:4f81d386-80d5-4a22-8b32-892f8b736094",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-10",
              "code": {
                  "coding": [
                      {
                          "code": "C03AA01",
                          "system": "http://www.whocc.no/atc",
                          "display": "Bendroflumethiazide"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:f28d6b82-31bf-4764-9259-12e78aa0374d",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-11",
              "code": {
                  "coding": [
                      {
                          "code": "C09AA03",
                          "system": "http://www.whocc.no/atc",
                          "display": "Lisinopril"
                      }
                  ]
              }
          }
      },
      {
          "fullUrl": "urn:uuid:893a36f7-cb07-442f-9ec7-b80d433a493c",
          "resource": {
              "resourceType": "Medication",
              "id": "eumfh-39-02-1-12",
              "code": {
                  "coding": [
                      {
                          "code": "H03AA01",
                          "system": "http://www.whocc.no/atc",
                          "display": "levothyroxine sodium"
                      }
                  ]
              }
          }
      }
  ]
}